Related Experiment Video
Updated: Sep 18, 2025

09:49
Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
Published on: February 23, 2024
2.0K
Extracellular Vesicle-Integrated Biomaterials in Bone Tissue Engineering Applications: Current Progress and Future
1Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000 People's Republic of China.
International Journal of Nanomedicine
|June 23, 2025
Summary
Extracellular vesicles (EVs) offer a promising cell-free therapy for bone regeneration, overcoming limitations of stem cell treatments. This review explores EV sources, mechanisms, modifications, and scaffold integration for enhanced bone repair strategies.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Cell Biology
Background:
- Aging populations and increased life expectancy drive a growing need for effective bone defect regeneration strategies.
- Bone tissue engineering traditionally relies on stem cells, biomaterials, and growth factors, but stem cell therapies present challenges like immune rejection and ectopic tissue formation.
- Extracellular vesicles (EVs) are emerging as a superior cell-free alternative due to their low immunogenicity, biocompatibility, and bioactivity.
Purpose of the Study:
- To provide a comprehensive overview of extracellular vesicle (EV)-based strategies for bone tissue engineering and regeneration.
- To explore the potential of EVs as a cell-free therapeutic approach for large bone defects.
- To discuss advancements in EV modification and integration with biomaterial scaffolds for controlled release.
Main Methods:
- Review of current literature on parent cell sources for EVs in bone regeneration.
- Analysis of the roles and mechanisms of EVs in promoting bone healing.
- Examination of EV modification strategies and their integration with biomaterial scaffolds for sustained release.
Main Results:
- EVs demonstrate significant potential for bone regeneration, offering advantages over traditional stem cell therapies.
- Various strategies exist for modifying EVs to enhance their therapeutic efficacy.
- Integration of EVs with biomaterial scaffolds enables controlled and sustained delivery to defect sites.
Conclusions:
- EV-based therapies represent a promising frontier in bone tissue engineering for addressing large bone defects.
- Further research into EV-functionalized biomaterials can accelerate the development of next-generation bone regenerative treatments.
- EVs offer a viable cell-free therapeutic avenue with high translational potential.

